| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 7 | |
| #2 | WIPO (World Intellectual Property Organization) | 5 | |
| #3 | EPO (European Patent Office) | 3 | |
| #4 | Australia | 2 | |
| #5 | Brazil | 2 | |
| #6 | Canada | 2 | |
| #7 | China | 2 | |
| #8 | Hong Kong | 1 | |
| #9 | Hungary | 1 | |
| #10 | Japan | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Peptides | |
| #3 | Therapeutic chemical compounds | |
| #4 | Climate change adaptation technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Boesen Thomas | 23 |
| #2 | Thomas Boesen | 3 |
| #3 | Jonassen Thomas Engelbrecht Nordkild | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2017068020A1 | W-peptide analog | |
| CN106232623A | There is the peptide analogues of branched-amino acid probe | |
| WO2015162483A1 | Alpha- and gamma-msh analogues | |
| WO2015162486A1 | Linear gamma msh with c- and / or n-terminal extensions of lysine and / or glutamic acid residues | |
| AU2013333765A1 | Alpha- and gamma-MSH analogues |